StonvexLoading…
StonvexStonvexStonvexCore line items from STC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $534.38M | $2.21B | $1.65B | $1.06B |
Operating Income | $7.15M | $60.86M | $42.08M | $15.02M |
Net Income | $3.13M | $30.44M | $21.62M | $7.63M |
EPS (Diluted) | $0.11 | $1.11 | $0.79 | $0.28 |
Total Assets | $2.65B | $2.70B | $2.67B | $2.68B |
Total Liabilities | $1.29B | $1.32B | $1.31B | $1.31B |
Cash & Equivalents | $138.35M | $233.37M | $202.99M | $190.04M |
Free Cash Flow OCF − CapEx | $-39.81M | $45.25M | $14.09M | $-31.45M |
Shares Outstanding | 27.58M | 27.37M | 27.36M | 27.27M |